Shmuel Ben Eliahu

Title: Shmuel Ben Eliahu: Innovator in Parkinson's Disease Treatment

Introduction

Shmuel Ben Eliahu is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of neurology, particularly in the treatment of Parkinson's disease. His innovative approach has the potential to improve the quality of life for individuals suffering from this debilitating condition.

Latest Patents

Shmuel holds a patent for "Methods for treatment of Parkinson's disease." This patent discloses a method for treating neurological or movement disorders, such as Parkinson's disease, through the parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI). The method involves the concomitant oral administration of these compounds, which may enhance the therapeutic effects for patients in need.

Career Highlights

Shmuel is currently associated with Neuroderm, Ltd., a company focused on developing innovative therapies for neurological disorders. His work at Neuroderm has positioned him as a key player in the advancement of treatment options for Parkinson's disease.

Collaborations

Shmuel collaborates with talented professionals in his field, including Tal Birnberg and Natalia Vostokova. These collaborations foster a dynamic environment for innovation and research, contributing to the development of effective treatments.

Conclusion

Shmuel Ben Eliahu's contributions to the treatment of Parkinson's disease through his patented methods highlight his dedication to improving patient outcomes. His work at Neuroderm and collaborations with other experts underscore the importance of innovation in the medical field.